Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

There's no better drive-thru porch-sipper than McDonald's Sweet Tea, but you can brew a copycat version with plenty of sugar ...

The pharmaceutical giant said multiple entities were still marketing and selling unbranded versions of its drug despite U.S.

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Shares in the maker of Ozempic crashed to three-year low after the pharma giant warned its injections were losing ground to ...

Skipping breakfast stops now, thanks to this list of 45 grab & go breakfasts that are as easy to throw together as they are ...

China is now well-known for its "copycat syndrome," particularly regarding its replicas of world-famous monuments, the originals of which are considered symbols of cultural status reflecting an empire ...

Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...

McDonald’s slow return of its Snack Wrap paved the way for one of the strangest battles in the ongoing fast-food war.

Shares in the $247 bln obesity drugmaker fell over 20% after it said sales would grow more slowly than expected. Competition ...